{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T04:12:35Z","timestamp":1768277555941,"version":"3.49.0"},"reference-count":13,"publisher":"BMJ","funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2017,8,3]]},"abstract":"<jats:p>A 64-year-old immunocompetent man developed a widespread pruritic and vesicular rash 2\u2009weeks after receiving the zoster vaccine (Zostavax). He had fever, bandaemia with normal total white blood cell count and mild transaminitis. PCR testing of serum and skin was positive for varicella zoster virus (VZV), while serum VZV IgG was negative. The analysis of single nucleotide polymorphism by PCR and sequencing from the skin swab was consistent with the vaccine strain. The patient received 1\u2009week of intravenous acyclovir and was discharged after all lesions had crusted. He continues to do well on follow-up with no significant complications.<\/jats:p>","DOI":"10.1136\/bcr-2017-221166","type":"journal-article","created":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T08:50:19Z","timestamp":1503391819000},"page":"bcr-2017-221166","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Zoster vaccine-associated primary varicella infection in an immunocompetent host"],"prefix":"10.1136","volume":"2017","author":[{"given":"Kaoru","family":"Harada","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Yale-New Haven Hospital, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Heaton","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Yale-New Haven Hospital, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology & Cell Biology, Columbia University College of Physicians & Surgeons, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marietta","family":"Vazquez","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaimie","family":"Meyer","sequence":"additional","affiliation":[{"name":"Department of Medicine, Infectious Diseases, AIDS Program, Yale University School of Medicine, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,8,22]]},"reference":[{"key":"2025082707155601000_2017.aug22_1.bcr-2017-221166.1","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(74)90144-5","article-title":"Live vaccine used to prevent the spread of varicella in children in hospital","volume":"2","author":"Takahashi","year":"1974","journal-title":"Lancet"},{"key":"2025082707155601000_2017.aug22_1.bcr-2017-221166.2","first-page":"729-31","article-title":"Update on recommendations for use of herpes zoster vaccine","volume":"63","author":"Hales","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025082707155601000_2017.aug22_1.bcr-2017-221166.3","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0889-8561(03)00100-0","article-title":"Immunization of immunocompromised persons","volume":"23","author":"Weber","year":"2003","journal-title":"Immunol Allergy Clin North Am"},{"key":"2025082707155601000_2017.aug22_1.bcr-2017-221166.4","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-152-9-201005040-00004"},{"key":"2025082707155601000_2017.aug22_1.bcr-2017-221166.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2011.02474.x"},{"key":"2025082707155601000_2017.aug22_1.bcr-2017-221166.6","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1128\/jvi.66.2.1016-1020.1992","article-title":"Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates","volume":"66","author":"LaRussa","year":"1992","journal-title":"J Virol"},{"key":"2025082707155601000_2017.aug22_1.bcr-2017-221166.7","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.06630-11"},{"key":"2025082707155601000_2017.aug22_1.bcr-2017-221166.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051016"},{"key":"2025082707155601000_2017.aug22_1.bcr-2017-221166.9","unstructured":"Package Insert - Zostavax (Frozen) (Internet). NJ 08889, USA: Whitehouse Station, 2017. https:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM132831.pdf. (accessed 8 Jul 2017)"},{"key":"2025082707155601000_2017.aug22_1.bcr-2017-221166.10","unstructured":"Package Insert - Varivax (Frozen) (Internet). NJ 08889, USA: Whitehouse Station,Merck & Co., INC, 2017. https:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM142813.pdf. (accessed 8 Jul 2017)"},{"key":"2025082707155601000_2017.aug22_1.bcr-2017-221166.11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu058"},{"key":"2025082707155601000_2017.aug22_1.bcr-2017-221166.12","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1086\/522125","article-title":"The safety profile of varicella vaccine: a 10-year review","volume":"197 Suppl 2","author":"Galea","year":"2008","journal-title":"J Infect Dis"},{"key":"2025082707155601000_2017.aug22_1.bcr-2017-221166.13","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2015-212688"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2017-221166","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T14:16:03Z","timestamp":1756304163000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2017-221166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,22]]},"references-count":13,"alternative-id":["10.1136\/bcr-2017-221166"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2017-221166","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,22]]}}}